StonvexLoading…
StonvexStonvexStonvexCore line items from CVSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2018 2018-06-30 | Annual 2017 2017-06-30 | Annual 2016 2016-06-30 |
|---|---|---|---|
Revenue | $160.49M | $151.61M | $129.57M |
Operating Income | $198.68M | $131.26M | $150.82M |
Net Income | $33.77M | $122.28M | $-3.17M |
EPS (Diluted) | $0.54 | $1.91 | $-0.05 |
Total Assets | $2.34B | $2.32B | $2.10B |
Total Liabilities | $816.57M | $639.69M | $509.80M |
Cash & Equivalents | $430.69M | $240.43M | $308.16M |
Free Cash Flow OCF − CapEx | $192.57M | $188.41M | $180.03M |
Shares Outstanding | 59.89M | 62.37M | 62.55M |